T. Rowe Price Associates
HALO icon

T. Rowe Price Associates’s Halozyme HALO Stock Holding History

T. Rowe Price Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Buy
259,390
+17,352
+7% +$1.22M ﹤0.01% 1090
2025
Q4 		$16.3M Sell
242,038
-583,387
-71% -$39.2M ﹤0.01% 1113
2025
Q3 		$60.5M Sell
825,425
-206,768
-20% -$13.7M 0.01% 747
2025
Q2 		$53.7M Sell
1,032,193
-154,537
-13% -$8.79M 0.01% 714
2025
Q1 		$75.7M Sell
1,186,730
-31,596
-3% -$1.84M 0.01% 608
2024
Q4 		$58.2M Sell
1,218,326
-52,195
-4% -$2.68M 0.01% 710
2024
Q3 		$72.7M Sell
1,270,521
-31,166
-2% -$1.79M 0.01% 643
2024
Q2 		$68.2M Buy
1,301,687
+2,843
+0.2% +$125K 0.01% 624
2024
Q1 		$52.8M Sell
1,298,844
-90,993
-7% -$3.41M 0.01% 717
2023
Q4 		$51.4M Sell
1,389,837
-178,074
-11% -$6.71M 0.01% 707
2023
Q3 		$59.9M Sell
1,567,911
-61,990
-4% -$2.54M 0.01% 634
2023
Q2 		$58.8M Sell
1,629,901
-3,283
-0.2% -$112K 0.01% 658
2023
Q1 		$62.4M Sell
1,633,184
-4,775
-0.3% -$224K 0.01% 622
2022
Q4 		$93.2M Buy
1,637,959
+22,939
+1% +$1.17M 0.02% 508
2022
Q3 		$63.9M Buy
1,615,020
+51,663
+3% +$2.28M 0.01% 584
2022
Q2 		$68.8M Sell
1,563,357
-1,890
-0.1% -$81.7K 0.01% 777
2022
Q1 		$62.4M Buy
1,565,247
+10,703
+0.7% +$381K 0.01% 892
2021
Q4 		$62.5M Buy
1,554,544
+39,576
+3% +$1.48M 0.01% 926
2021
Q3 		$61.6M Sell
1,514,968
-7,941
-0.5% -$332K 0.01% 938
2021
Q2 		$69.2M Buy
1,522,909
+9,814
+0.6% +$434K 0.01% 918
2021
Q1 		$63.1M Buy
1,513,095
+266,361
+21% +$12.2M 0.01% 922
2020
Q4 		$53.2M Buy
1,246,734
+1,183,456
+1,870% +$42.5M 0.01% 940
2020
Q3 		$1.66M Sell
63,278
-342,852
-84% -$9.55M ﹤0.01% 1603
2020
Q2 		$10.9M Buy
406,130
+325,955
+407% +$7.35M ﹤0.01% 1279
2020
Q1 		$1.44M Buy
80,175
+8,545
+12% +$162K ﹤0.01% 1582
2019
Q4 		$1.27M Buy
71,630
+5,677
+9% +$98.3K ﹤0.01% 1793
2019
Q3 		$1.02M Buy
65,953
+663
+1% +$10.9K ﹤0.01% 1816
2019
Q2 		$1.12M Buy
65,290
+6,005
+10% +$96.9K ﹤0.01% 1802
2019
Q1 		$954K Buy
59,285
+400
+0.7% +$6.48K ﹤0.01% 1865
2018
Q4 		$861K Buy
58,885
+222
+0.4% +$3.54K ﹤0.01% 1862
2018
Q3 		$1.07M Sell
58,663
-563
-1% -$9.86K ﹤0.01% 1862
2018
Q2 		$999K Buy
59,226
+13,581
+30% +$257K ﹤0.01% 1839
2018
Q1 		$894K Buy
45,645
+267
+0.6% +$5.17K ﹤0.01% 1836
2017
Q4 		$919K Sell
45,378
-9,130
-17% -$168K ﹤0.01% 1848
2017
Q3 		$947K Buy
54,508
+10,200
+23% +$138K ﹤0.01% 1833
2017
Q2 		$568K Buy
44,308
+8
+0% +$107 ﹤0.01% 2010
2017
Q1 		$574K Sell
44,300
-6,600
-13% -$83.4K ﹤0.01% 2011
2016
Q4 		$503K Sell
50,900
-10,600
-17% -$116K ﹤0.01% 2035
2016
Q3 		$743K Buy
61,500
+11,300
+23% +$115K ﹤0.01% 1860
2016
Q2 		$433K Buy
50,200
+7,900
+19% +$78K ﹤0.01% 2019
2016
Q1 		$401K Hold
42,300
– – ﹤0.01% 2065
2015
Q4 		$733K Sell
42,300
-600
-1% -$9.56K ﹤0.01% 1800
2015
Q3 		$576K Buy
42,900
+4,000
+10% +$80.3K ﹤0.01% 1893
2015
Q2 		$878K Buy
38,900
+10,200
+36% +$179K ﹤0.01% 1798
2015
Q1 		$410K Sell
28,700
-900
-3% -$13K ﹤0.01% 2058
2014
Q4 		$286K Hold
29,600
– – ﹤0.01% 2196
2014
Q3 		$269K Hold
29,600
– – ﹤0.01% 2193
2014
Q2 		$292K Sell
29,600
-31,100
-51% -$264K ﹤0.01% 2191
2014
Q1 		$771K Sell
60,700
-10,500
-15% -$156K ﹤0.01% 1759
2013
Q4 		$1.07M Sell
71,200
-5,700
-7% -$73.3K ﹤0.01% 1667
2013
Q3 		$849K Buy
76,900
+7,800
+11% +$65K ﹤0.01% 1710
2013
Q2 		$549K Buy
+69,100
New +$440K ﹤0.01% 1833

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's HALO Position: Q1 2026 in Review

T. Rowe Price Associates increased its Halozyme (HALO) stake by 7.2% in Q1 2026, buying an estimated $1.22M and bringing the position to 259,390 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

T. Rowe Price Associates first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.2M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • T. Rowe Price Associates held 259,390 shares of Halozyme worth $16.8M as of Q1 2026.
  • T. Rowe Price Associates bought 17,352 Halozyme shares in Q1 2026, an estimated $1.22M.
  • Halozyme made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1090 holding.
  • T. Rowe Price Associates first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Halozyme position peaked at $93.2M in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.